Get the Stockscreener App
3.5598
2.20%
-0.0702
Relay Therapeutics Inc stock is traded at $3.5598, with a volume of 3.54M.
It is down -2.20% in the last 24 hours and up +2.60% over the past month.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
See More
Previous Close:
$3.63
Open:
$3.55
24h Volume:
3.54M
Relative Volume:
1.72
Market Cap:
$610.34M
Revenue:
$25.55M
Net Income/Loss:
$-341.97M
P/E Ratio:
-1.2714
EPS:
-2.8
Net Cash Flow:
$-304.44M
1W Performance:
-3.53%
1M Performance:
+2.60%
6M Performance:
-20.58%
1Y Performance:
-56.81%
1-Day Range:
$3.485
$3.71
1-Week Range:
$3.485
$3.88
52-Week Range:
$1.775
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
Name
Relay Therapeutics Inc
Sector
Industry
Phone
617-370-8837
Address
399 BINNEY STREET, CAMBRIDGE
Compare RLAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.56 | 620.63M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.84 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.19 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.38 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
677.41 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
300.18 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | Wells Fargo | Equal Weight |
| Sep-10-24 | Resumed | Goldman | Buy |
| Sep-10-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-10-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-20-23 | Upgrade | Jefferies | Underperform → Hold |
| Apr-19-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-23 | Initiated | Raymond James | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Sep-30-22 | Initiated | Barclays | Equal Weight |
| Sep-02-22 | Initiated | Stifel | Buy |
| Jun-06-22 | Initiated | Jefferies | Underperform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Jul-21-21 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-08-20 | Initiated | JMP Securities | Mkt Outperform |
| Nov-05-20 | Initiated | H.C. Wainwright | Buy |
| Aug-10-20 | Initiated | Cowen | Outperform |
| Aug-10-20 | Initiated | Goldman | Buy |
| Aug-10-20 | Initiated | Guggenheim | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
View All
Relay Therapeutics Inc Stock (RLAY) Latest News
What makes Relay Therapeutics Inc. stock price move sharplyPost Market Recommendation With High Returns - jammulinksnews.com
Rahmer Peter sells Relay Therapeutics (RLAY) stock worth $62,946 By Investing.com - Investing.com Canada
Relay Therapeutics president sells $113k in stock - Investing.com
Relay Therapeutics Executives Sell Shares - TradingView
Published on: 2025-07-29 23:02:46 - metal.it
Relay Therapeutics has positive read from Celcuity data, says Barclays - 富途牛牛
Published on: 2025-07-29 04:36:35 - beatles.ru
What is the risk reward ratio of investing in Relay Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
When is Relay Therapeutics Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - jammulinksnews.com
Price Floor Holding on Relay Therapeutics Inc. — Rebound PossibleProfit Focused Stock Screener Results Released - metal.it
What are the technical indicators suggesting about Relay Therapeutics Inc.Achieve breakthrough performance in the market - jammulinksnews.com
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionAchieve breakthrough profits with smart strategies - jammulinksnews.com
What are Relay Therapeutics Inc. company’s key revenue driversGet expert analysis on top stock picks - jammulinksnews.com
Does Relay Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough investment performance - jammulinksnews.com
How does Relay Therapeutics Inc. compare to its industry peersMaximize gains with proven stock analysis - jammulinksnews.com
Is Relay Therapeutics Inc. a growth stock or a value stockGet daily updates on the hottest stocks - jammulinksnews.com
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Invest in high-yield stocks with confidence - jammulinksnews.com
Is Relay Therapeutics Inc. stock overvalued or undervaluedExplosive capital appreciation - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Build wealth steadily with smart stock selection - jammulinksnews.com
Why Relay Therapeutics Inc. stock attracts strong analyst attentionFree Stock Investment Growth Plan - metal.it
What analysts say about Relay Therapeutics Inc. stockExceptional growth trajectory - PrintWeekIndia
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - Yahoo Finance
Is Relay Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia
When is the best time to buy Relay Therapeutics Inc. stockMassive wealth growth - jammulinksnews.com
Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com
What drives Relay Therapeutics Inc. stock priceTremendous growth potential - PrintWeekIndia
Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com
Relay Therapeutics Inc Stock (RLAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Relay Therapeutics Inc Stock (RLAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
2.79%
2.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):